Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teija Parkkari

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Biophysical Journal|February 10, 2010
Electrostatic tuning of cellular excitabilitySara I Börjesson, Teija Parkkari, Sven Hammarström, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 8, 2012
Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonistsSari Yrjölä, Tuomo Kalliokoski, Tuomo Laitinen, et al.
Frontiers in Behavioral Neuroscience|October 19, 2018
Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning TaskTuukka O Piiponniemi, Teija Parkkari, Taneli Heikkinen, et al.
Plos One|December 28, 2020
Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's diseaseTaneli Heikkinen, Timo Bragge, Niina Bhattarai, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivativesTeija Parkkari, Juha R Savinainen, Anu L Rauhala, et al.
Bioorganic & Medicinal Chemistry|January 13, 2006
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE)Teija Parkkari, Outi M H Salo, Kristiina M Huttunen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 6, 2013
1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modellingHeikki Käsnänen, Anna Minkkilä, Susanna Taupila, et al.
Journal of Molecular Modeling|September 10, 2015
Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitorsAgnieszka A Kaczor, Katarzyna M Targowska-Duda, Jayendra Z Patel, et al.
Plos One|October 8, 2014
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A)Juha R Savinainen, Jayendra Z Patel, Teija Parkkari, et al.
Journal of Medicinal Chemistry|January 20, 2006
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological dataOuti M H Salo, Juha R Savinainen, Teija Parkkari, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Biophysical Journal|February 10, 2010
Electrostatic tuning of cellular excitabilitySara I Börjesson, Teija Parkkari, Sven Hammarström, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 8, 2012
Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonistsSari Yrjölä, Tuomo Kalliokoski, Tuomo Laitinen, et al.
Frontiers in Behavioral Neuroscience|October 19, 2018
Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning TaskTuukka O Piiponniemi, Teija Parkkari, Taneli Heikkinen, et al.
Plos One|December 28, 2020
Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's diseaseTaneli Heikkinen, Timo Bragge, Niina Bhattarai, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivativesTeija Parkkari, Juha R Savinainen, Anu L Rauhala, et al.
Bioorganic & Medicinal Chemistry|January 13, 2006
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE)Teija Parkkari, Outi M H Salo, Kristiina M Huttunen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 6, 2013
1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modellingHeikki Käsnänen, Anna Minkkilä, Susanna Taupila, et al.
Journal of Molecular Modeling|September 10, 2015
Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitorsAgnieszka A Kaczor, Katarzyna M Targowska-Duda, Jayendra Z Patel, et al.
Plos One|October 8, 2014
Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A)Juha R Savinainen, Jayendra Z Patel, Teija Parkkari, et al.
Journal of Medicinal Chemistry|January 20, 2006
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological dataOuti M H Salo, Juha R Savinainen, Teija Parkkari, et al.
Pageof 3